Hint mode is switched on Switch off
For swift navigation between sections

Altamira Therapeutics
LEI 549300JFK0RDL3EKDH83

Liquidated
Organization name
Altamira Therapeutics Ltd (formerly Auris Medical Holding Ltd)
Country name
Switzerland
Country of registration
Bermuda
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds
  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Altamira Therapeutics Ltd (formerly Auris Medical Holding Ltd) is dedicated to developing therapeutics that address important unmet medical needs. The Company is currently active in RNA therapeutics, allergy and viral infections, and inner ear disorders

Awards

Documentation

IFRS/US GAAP reports

2020
2019
2018
2017
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Codes

  • LEI
    549300JFK0RDL3EKDH83
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • UID
    CHE108297413
Registration is required to get access.